1999
DOI: 10.1046/j.1365-2249.1999.00869.x
|View full text |Cite
|
Sign up to set email alerts
|

Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors

Abstract: SUMMARYIn peripheral blood progenitor cell (PBPC) collections from patients with solid tumour or haematological malignancy, monocytes were separated into two subpopulations. The majority of monocytes expressed CD14 at a high density without CD16 antigen (the CD14 þ CD16 ¹ monocytes). The remaining monocytes co-expressed CD14 and CD16 (the CD14þ monocytes amounted to 20·6 Ϯ 15·8%, while those in peripheral blood (PB) obtained from healthy volunteers were 7·3 Ϯ 3·1% (P < 0·05 CD16þ monocytes in which the propor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
20
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(25 citation statements)
references
References 28 publications
(42 reference statements)
5
20
0
Order By: Relevance
“…The LPS receptor (CD14) is essential in the control of monocyte function, as it initiates many signaling cascades inside the cell [24]. As CD14 is not highly expressed on a large proportion of gmPB monocytes, they may respond poorly to LPS stimulation, and thus, LPS may not be the most effective factor for use in activation studies [25]. Recently, synergistic LPS signaling has been described through CD14 interaction with TLR4 [26].…”
Section: Discussionmentioning
confidence: 99%
“…The LPS receptor (CD14) is essential in the control of monocyte function, as it initiates many signaling cascades inside the cell [24]. As CD14 is not highly expressed on a large proportion of gmPB monocytes, they may respond poorly to LPS stimulation, and thus, LPS may not be the most effective factor for use in activation studies [25]. Recently, synergistic LPS signaling has been described through CD14 interaction with TLR4 [26].…”
Section: Discussionmentioning
confidence: 99%
“…CD14loCD16hi monocytes also have phagocytic capacity [70], although perhaps lower than that of CD14hi monocytes [60]. This CD14loCD16hi subset expands (to greater than 20Ϫ40% of circulating monocytes) in response to inflammation [60] and malignancy [71]. Their expansion in peripheral blood may result from mobilization from the marginal pool [72].…”
Section: Two Distinct Monocyte Subsets Exist In Peripheral Bloodmentioning
confidence: 99%
“…About 90% of peripheral blood Mo consists of cells CD14+ CD16− (usually considered as "classical Mo"). Although the remaining Mo express CD16, they also present heterogeneity in CD14 expression [33,34]. CD14dim CD16+ Mo are regarded as pro-inflammatory because upon LPS stimulation they produce more TNF-α than classical Mo and little, if any, IL-10 [35,36].…”
Section: Discussionmentioning
confidence: 99%